The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,434,027 in first-year total cost, median $982,927.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-2 (M4)]3
- Special Emphasis Panel[ZDK1 GRB-M (M4)]2
- Special Emphasis Panel[ZDK1 GRB-M (O4)]2
- Special Emphasis Panel[ZDK1 GRB-6 (M4)]1
- Special Emphasis Panel[ZDK1 GRB-M (J3)]1
Most frequent institutions
- 3-C INSTITUTE FOR SOCIAL DEVELOPMENT1
- CAPILLARY BIOMEDICAL, INC.1
- CELLF-BIO INC1
- HEALIONICS CORPORATION1
- HEMOTEK1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Relative Bioavailability of Subcutaneous Insulin over Extended Durations of Infusion Set Use2R44DK110969-02 | STRASMA, PAUL J | CAPILLARY BIOMEDICAL, INC., CA | $1,750,000 | ZDK1 |
| 2018 | BioSphincter to Treat Fecal Incontinence. Phase 1/2 Clinical Trial. SBIR Phase IIB2R44DK105593-04 | BITAR, KHALIL N | CELLF-BIO INC, VA | $1,284,815 | ZDK1 |
| 2018 | Novel Biguanides to Treat Type 2 Diabetes2R44DK096803-04 | BATCHELOR, KEN W | NOVATARG, INC., NC | $1,000,000 | ZDK1 |
| 2018 | Phase IIB: Exploratory Clinical trials for The V Needle2R44DK101253-04 | ROUSCHE, PATRICK J | HEMOTEK, CA | $994,000 | ZDK1 |
| 2018 | Living with CKD: An E-Learning Platform for Adolescents with CKD about the Disease and its Management2R44DK108421-02 | CHILDRESS, DEBRAFERRIS, MARIA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $504,984 | ZDK1 |
| 2018 | Novel Saliva-based Renal Function Test Platform1R44DK116383-01A1 | BESHAY, MANALKALANTAR-ZADEH, KAMYAR | INTELLIGENT OPTICAL SYSTEMS, INC., CA | $252,199 | ZDK1 |
| 2018 | Optimization of Non Invasive Brain Stimulation for Diabetic Neuropathic Pain1R44DK117710-01A1 | DIPIETRO, LAURAWAGNER, TIMOTHY ANDREW | HIGHLAND INSTRUMENTS, INC., MA | $224,763 | ZDK1 |
| 2017 | A Bullet Proof vascular graft to prevent dialysis access cannulation injury2R44DK108488-02 | KNIGHT, JOSEPH | INNAVASC MEDICAL, INC., NC | $982,927 | ZDK1 |
| 2017 | Clinical Study of an Extended-Patency Dialysis Access Graft1R44DK116380-01 | MARSHALL, ANDREWTRAN, NAM T | HEALIONICS CORPORATION, WA | $440,339 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.